NCT01016054View on ClinicalTrials.gov

A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
CarcinomaOvarian CancerOvarian DiseasesOvarian Neoplasms
Interventions
BIOLOGICAL

AGS-8M4

IV infusion

DRUG

Pegylated liposomal doxorubicin (PLD)

IV infusion

DRUG

gemcitabine

IV infusion

DRUG

carboplatin

IV infusion

Trial Locations (1)

91010

Duarte

Sponsors

Collaborators (1)

Agensys, Inc.
All Listed Sponsors
collaborator

Agensys, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY